{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:16:30Z","timestamp":1771402590044,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nigde Omer Halisdemir University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To report the results of Endpoint Management (EpM) with PASCAL laser in the treatment of chronic central serous retinopathy (CSR). A 577\u00a0nm yellow laser was applied using PASCAL with EpM to 11 eyes on 11 patients who were followed for CSR for at least 12 months in this prospective study. The laser spot size was set to 200\u00a0\u03bcm, the pulse duration was 15 msec, and the spot spacing was set to 0.25 diameter. In cases where recurrence was present or subretinal fluid did not disappear, the laser was applied again three months after the last laser treatment. Detailed anterior segment and fundus examination, intraocular pressure measurement, and optical coherence tomography (OCT) were performed. Fundus fluorescein angiography (FFA) was performed at the time of diagnosis and at the end of the 6th month. The treatment was applied once for four patients (38.3%), two times for five patients (45.4%), three times for one patient (9.1%), and five times for one patient (9.1%) to achieve these results. The average pre-laser central macular thickness (CMT) value was 343.3\u2009\u00b1\u200950.2\u00a0\u03bcm, and post-treatment, the CMT value decreased to 233.1\u2009\u00b1\u200920.3\u00a0\u03bcm (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008). According to baseline examinations, the patients\u2019 mean pre-treatment BCVA (logMAR) value was 0.46\u2009\u00b1\u20090.18, which improved to 0.34\u2009\u00b1\u20090.31 with treatment (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.012). Five patients (45.4%) had retinal pigment epithelial changes, and no other patients had complications. PASCAL with EpM using a 577\u00a0nm yellow laser is an effective and reliable treatment for patients with chronic CSR. The frequency of retinal pigment epithelial change was higher than in other studies in the literature in our study.\n                  <\/jats:p>","DOI":"10.1007\/s10103-025-04522-8","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T23:01:04Z","timestamp":1749423664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The results of subthreshold 577\u00a0nm yellow laser application using pascal laser system in patients with chronic central serous chorioretinopathy"],"prefix":"10.1007","volume":"40","author":[{"given":"Mehmet","family":"\u00d6nen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00fcr\u015fad Ramazan","family":"Zor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkut","family":"K\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Y\u0131ld\u0131r\u0131m Bi\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer","family":"\u00d6zer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"4522_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ceo.14201","volume":"51","author":"AT Fung","year":"2023","unstructured":"Fung AT, Yang Y, Kam AW (2023) Central serous chorioretinopathy: a review. Clin Exp Ophthalmol 51:243\u2013270","journal-title":"Clin Exp Ophthalmol"},{"key":"4522_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/aos.12779","volume":"94","author":"KH Wong","year":"2016","unstructured":"Wong KH, Lau KP, Chhablani J (2016) Central serous chorioretinopaty: what we have learnt so Far. Acta Ophthalmol 94:321\u2013325","journal-title":"Acta Ophthalmol"},{"key":"4522_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/eye.2014.315","volume":"29","author":"NK Yadav","year":"2015","unstructured":"Yadav NK, Jayadev C, Mohan A et al (2015) Subthreshold micropulse yellow laser (577nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye 29:258\u2013265","journal-title":"Eye"},{"key":"4522_CR4","unstructured":"Iacono P, Battaglia PM, Falcomata B et al (2016) Central serous chorioretinopathy: a mini review. Ophthalmic Res.;5576\u20135583"},{"key":"4522_CR5","first-page":"52","volume":"53","author":"G Ledesma-Gil","year":"2021","unstructured":"Ledesma-Gil G, Desmettre T, Mainster MA (2021) Bacillary layer detachment after photodynamic therapy for central serous chorioretinopathy. Retin Cases Brief Rep 53:52\u201356","journal-title":"Retin Cases Brief Rep"},{"key":"4522_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","volume":"122","author":"K Fujita","year":"2015","unstructured":"Fujita K, Imamura Y, Shinoda K (2015) One-year outcomes with half d\u00f6\u015fe verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 122:555\u2013561","journal-title":"Ophthalmology"},{"key":"4522_CR7","first-page":"1","volume":"0","author":"K Jeffrey","year":"2016","unstructured":"Jeffrey K, Luttrull (2016) Low-intensity\/high-density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina 0:1\u20136","journal-title":"Retina"},{"key":"4522_CR8","doi-asserted-by":"crossref","unstructured":"Wood EH, Karth PA, Sanislo SR et al (2017) Non-damaging retinal laser theraphy for treatment of central serous chorioretinopathy, vol 37. Retina, pp 1021\u20131033","DOI":"10.1097\/IAE.0000000000001386"},{"key":"4522_CR9","doi-asserted-by":"crossref","unstructured":"Gawecki M \u0130ncrease in central retinal edema after subthreshold diode micropulse laser treatment of chronic central serous chorioretinopathy. Case reports in ophthalmological medicine. Published online 2015 jun 9.","DOI":"10.1155\/2015\/813414"},{"issue":"1","key":"4522_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1364\/BOE.475705","volume":"14","author":"D Veysset","year":"2023","unstructured":"Veysset D, Zhuo Y, Hattori J, Buckhory M, Palanker D (2023) Interferometric thermometry of ocular tissues for retinal laser therapy. Biomed Opt Express 14(1):37\u201353","journal-title":"Biomed Opt Express"},{"key":"4522_CR11","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1167\/iovs.15-18981","volume":"57","author":"D Lavinsky","year":"2016","unstructured":"Lavinsky D, Wang J, Huie P et al (2016) Nondamaging retinal laser therapy: rationale and applications to the macula. Retina. \u0130nvest Ophthalmol Vis Sci 57:2488\u20132500","journal-title":"\u0130nvest Ophthalmol Vis Sci"},{"key":"4522_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/0301-4738.126179","volume":"62","author":"NK Yadav","year":"2014","unstructured":"Yadav NK, Jayadev C, Rajendran A et al (2014) Recent developments in retinal lasers and delivery systems. \u0130ndian J Ophthalmol 62:50\u201354","journal-title":"\u0130ndian J Ophthalmol"},{"key":"4522_CR13","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1167\/iovs.10-5917","volume":"52","author":"C Sramek","year":"2011","unstructured":"Sramek C, Mackanos M, Spitler R (2011) Non-damaging retinal phototherapy: dynamic range of heat shock protein expression. \u0130nvest Ophthalmol Vis Sci 52:1780\u20131787","journal-title":"\u0130nvest Ophthalmol Vis Sci"},{"key":"4522_CR14","first-page":"2976","volume":"42","author":"T Desmettre","year":"2001","unstructured":"Desmettre T, Maurage CA, Mordon S (2001) Heat shock protein hyperexpression on chorioretinal layers after transpupillary thermotherapy. \u0130nvest Ophthalmol Vis Sci 42:2976\u20132980","journal-title":"\u0130nvest Ophthalmol Vis Sci"},{"key":"4522_CR15","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/IAE.0000000000000458","volume":"35","author":"JK Luttrull","year":"2015","unstructured":"Luttrull JK, Chang DB, Margolis BW et al (2015) Laser resentization of medically unresponsive neovascular age-related macular degeneration: efficacy and implications. Retina 35:1184\u20131194","journal-title":"Retina"},{"key":"4522_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1379\/1466-1268(1998)003<0228:HSPROS>2.3.CO;2","volume":"3","author":"A Samali","year":"1998","unstructured":"Samali A, Orrenius S (1998) Heat shock proteins: regulators of stress response and apoptosis. Cell Stress Chaperones 3:228\u2013236","journal-title":"Cell Stress Chaperones"},{"key":"4522_CR17","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","volume":"115","author":"SN Chen","year":"2008","unstructured":"Chen SN, Hwang JF, Tseng LF et al (2008) Suthreshold diode micropulse photocoagulation for the treatment of central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 115:2229\u20132234","journal-title":"Ophthalmology"},{"key":"4522_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3928\/23258160-20130909-08","volume":"44","author":"l Roisman","year":"2013","unstructured":"Roisman l, Magalh\u00e3es FP, Lavinsky D et al (2013) Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Ophthalmic Surg Lasers Imaging Retina 44:465\u2013470","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4522_CR19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/112067210801800613","volume":"18","author":"P Lanzetta","year":"2008","unstructured":"Lanzetta P, Furlan F, Morgante L et al (2008) Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 18:934\u2013940","journal-title":"Eur J Ophthalmol"},{"key":"4522_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00417-008-1014-1","volume":"247","author":"F Ricci","year":"2009","unstructured":"Ricci F, Missiroli F, Regine F et al (2009) Indocyanine green enhanced subthreshold diode laser micropulse photocoagulation treatment of central serous chorioretinopathy. Grafes Arch Clin Exp Ophthalmol 247:597\u2013607","journal-title":"Grafes Arch Clin Exp Ophthalmol"},{"key":"4522_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/eye.2011.282","volume":"26","author":"MJ Koss","year":"2012","unstructured":"Koss MJ, Beger I, Koch FH (2012) Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye 26:307\u2013314","journal-title":"Eye"},{"key":"4522_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-015-2965-7","volume":"253","author":"JY Kim","year":"2015","unstructured":"Kim JY, Park HS, Kim SY (2015) Short-term efficacy of subthreshold micropulse yellow laser (577 nm) photocoagulation for chronic central serous chorioretinopathy. Grafes Arch Clin Exp Ophthalmol 253:1\u20137","journal-title":"Grafes Arch Clin Exp Ophthalmol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04522-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04522-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04522-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:23:32Z","timestamp":1771399412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04522-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4522"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04522-8","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Clinical Research Ethics Committee of Ni\u011fde \u00d6mer Halisdemir University (Date:05.12.2019, Clinical trial number:2019\/12\u2009\u2212\u200907). All participants were thoroughly informed about the procedures and written as well as verbally informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in figures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}